Comerica Bank’s BioNTech BNTX Stock Holding History

Comerica Bank’s Portfolio BNTX Stock Details BNTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	$594K	Sell	4,147 -13	-0.3%	-$2K	﹤0.01%	1700
2022 Q3	$561K	Buy	4,160 +362	+10%	+$55.3K	﹤0.01%	1736
2022 Q2	$625K	Sell	3,798 -27	-0.7%	-$4.13K	0.01%	1749
2022 Q1	$588K	Sell	3,825 -41	-1%	-$6.89K	﹤0.01%	1807
2021 Q4	$605K	Sell	3,866 -312	-7%	-$85.5K	﹤0.01%	1791
2021 Q3	$1.16M	Sell	4,178 -9,169	-69%	-$2.91M	0.01%	1609
2021 Q2	$4.43M	Sell	13,347 -8	-0.1%	-$1.51K	0.03%	789
2021 Q1	$2.31M	Buy	13,355 +503	+4%	+$53.4K	0.01%	1272
2020 Q4	$1.39M	Buy	12,852 +621	+5%	+$61K	0.01%	1521
2020 Q3	$1.08M	Buy	12,231 +492	+4%	+$35.3K	0.01%	1509
2020 Q2	$1.22M	Buy	11,739 +606	+5%	+$30.3K	0.01%	1391
2020 Q1	$532K	Buy	+11,133	New	+$433K	﹤0.01%	1705

Other funds holding BNTX

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Comerica Bank's BNTX Position: Q4 2022 in Review

Comerica Bank reduced its BioNTech (BNTX) stake by 0.31% in Q4 2022, selling an estimated $2K and leaving 4,147 shares worth $594K. The position accounts for ﹤0.01% of the portfolio, ranked #1700.

Comerica Bank first reported a position in BNTX in Q1 2020 and has held it in 12 quarters since. The position peaked at $4.43M in Q2 2021. 320 funds tracked by Wall St. Rank hold BNTX as of Q4 2022.

Comerica Bank held 4,147 shares of BioNTech worth $594K as of Q4 2022.
Comerica Bank sold 13 BioNTech shares in Q4 2022, an estimated $2K.
BioNTech made up ﹤0.01% of Comerica Bank's portfolio in Q4 2022, its #1700 holding.
Comerica Bank first reported a position in BioNTech in Q1 2020 and has held it in 12 quarters since.
Comerica Bank's BioNTech position peaked at $4.43M in Q2 2021.
320 funds tracked by Wall St. Rank held BioNTech as of Q4 2022.

Based on Comerica Bank's 13F filing for Q4 2022, filed 26 Jan 2023.